Welcome to the Champions Portal

Here you’ll find valuable information to help you in your role as a TNBC Champion…

Resources

Introducing TNBC Webinars

We launched our TNBC webinar series in partnership with RCNi on September 19th, bringing together nurses and expert speakers to share the latest insights and tools in TNBC care.

Missed our TNBC webinar?

We’re delighted to share the full recordings with anyone who couldn’t join us live.

Watch now
Watch now

Upcoming TNBC Webinar

TNBC: Genomics and Pathology

24th April 2026 | 1pm - 2pm

Explore how genomics is transforming TNBC care, uncovering BRCA inheritance, and advancing clinical testing.

Register now for free
Register now for free

Upcoming Events

Stay Connected

Join the Champions WhatsApp Community

Join
Join

Head to the UK Charity for TNBC Online Community

Join
Join

Follow us on Instagram

Follow
Follow

Follow us on Facebook

Follow
Follow

Latest News

News
What the New National Cancer Plan means for people with triple negative breast cancer
What the New National Cancer Plan means for people with triple negative breast cancer

What does the new National Cancer Plan mean for people with triple negative breast cancer (TNBC)? Our latest update explains the potential impact on care and treatment.

Read More →
Robin Woolcock joins LACE Partners’ podcast to highlight the workplace impact of TNBC
Robin Woolcock joins LACE Partners’ podcast to highlight the workplace impact of TNBC

Robin Woolcock, founder of the UK Charity for Triple Negative Breast Cancer, joins LACE Partners’ podcast to raise awareness of TNBC and spark vital conversations about how workplaces can better support those affected.

Read More →
The Patient Voice helps guide BioNTech design for UK Drug Trial 
The Patient Voice helps guide BioNTech design for UK Drug Trial 

The UK Charity for Triple Negative Breast Cancer (TNBC) recently asked our Patient Advisory Panel (PAP) members a series of important questions on behalf of the pharmaceutical company BioNTech. Their answers provided critical information which will now be used by BioNTech to help inform the design of a trial for an investigational drug intended for people with the metastatic form of TNBC. 

Read More →
Charity helps NICE (the National Institute for Health and Care) to recommend new treatment for people with TNBC
Charity helps NICE (the National Institute for Health and Care) to recommend new treatment for people with TNBC

New NICE guidance on TNBC treatment reflects input from The UK Charity for TNBC’s Patient Advisory Panel (PAP). Your involvement is helping to shape more effective care for those affected by TNBC.

Read More →
Report from ESMO Breast 2025
Report from ESMO Breast 2025

The UK Charity for TNBC attended ESMO Breast 2025 in Munich, presenting a poster, ‘Needs of People with Triple Negative Breast Cancer (TNBC): The Patients Voice’, based on roundtable discussions in partnership with RCNi, produced by Dr Hira Yousef and Professor Chris Twelves.

Read More →
Make 2nds Count can help find a trial for you!
Make 2nds Count can help find a trial for you!

Make 2nds Count has relaunched its free clinical trials service, helping secondary breast cancer patients, including those with triple negative breast cancer, find suitable trials. This nurse-led support offers expert guidance and tailored searches.

Read More →
Government Recognises That TNBC Needs A Specific Approach
Government Recognises That TNBC Needs A Specific Approach

Recently in parliament, government representatives recognised that a cancer specific approach is needed to meet the challenges in cancer care and to improve outcomes for people living with triple negative breast cancer.

Read More →
We are looking for more TNBC Champions!
We are looking for more TNBC Champions!

Apply now for the free TNBC Study Day on 21st March 2025 in London. Limited to 25 places, this CPD-certified event is your chance to become a TNBC Nurse Champion. Educate, engage, and lead as the expert in your team. Apply via RCNi today!

Read More →
Keytruda (Pembroluzimab) Positive Results!
Keytruda (Pembroluzimab) Positive Results!

Positive results have been shared by pharmaceutical company MSD from their recent trial with Keytruda, combined with chemotherapy, as a promising treatment for high-risk early-stage triple negative breast cancer patients

Read More →
The UK Charity for TNBC Becomes NICE Stakeholder
The UK Charity for TNBC Becomes NICE Stakeholder

The UK Charity for Triple Negative Breast Cancer is delighted to become a NICE stakeholder, contributing patient perspectives to the development of key breast cancer treatments.

Read More →
Education Grants for Nurses!
Education Grants for Nurses!

The UK Charity for Triple Negative Breast Cancer is delighted to be announcing a Foundation to provide grants to fund further education for individual breast cancer nurses.

Read More →
The UK Charity for TNBC Appears on BOPA Podcast
The UK Charity for TNBC Appears on BOPA Podcast

Robin Woolcock, founder of the UK Charity for Triple Negative Breast Cancer, joins Michal Sladkowski on the Let's Talk About SACT podcast. He discusses his experience with TNBC, the motivation behind the charity, and the support available for patients and staff.

Read More →

Latest News

News
What the New National Cancer Plan means for people with triple negative breast cancer
What the New National Cancer Plan means for people with triple negative breast cancer

What does the new National Cancer Plan mean for people with triple negative breast cancer (TNBC)? Our latest update explains the potential impact on care and treatment.

Read More →
Robin Woolcock joins LACE Partners’ podcast to highlight the workplace impact of TNBC
Robin Woolcock joins LACE Partners’ podcast to highlight the workplace impact of TNBC

Robin Woolcock, founder of the UK Charity for Triple Negative Breast Cancer, joins LACE Partners’ podcast to raise awareness of TNBC and spark vital conversations about how workplaces can better support those affected.

Read More →
The Patient Voice helps guide BioNTech design for UK Drug Trial 
The Patient Voice helps guide BioNTech design for UK Drug Trial 

The UK Charity for Triple Negative Breast Cancer (TNBC) recently asked our Patient Advisory Panel (PAP) members a series of important questions on behalf of the pharmaceutical company BioNTech. Their answers provided critical information which will now be used by BioNTech to help inform the design of a trial for an investigational drug intended for people with the metastatic form of TNBC. 

Read More →
Charity helps NICE (the National Institute for Health and Care) to recommend new treatment for people with TNBC
Charity helps NICE (the National Institute for Health and Care) to recommend new treatment for people with TNBC

New NICE guidance on TNBC treatment reflects input from The UK Charity for TNBC’s Patient Advisory Panel (PAP). Your involvement is helping to shape more effective care for those affected by TNBC.

Read More →
Report from ESMO Breast 2025
Report from ESMO Breast 2025

The UK Charity for TNBC attended ESMO Breast 2025 in Munich, presenting a poster, ‘Needs of People with Triple Negative Breast Cancer (TNBC): The Patients Voice’, based on roundtable discussions in partnership with RCNi, produced by Dr Hira Yousef and Professor Chris Twelves.

Read More →
Make 2nds Count can help find a trial for you!
Make 2nds Count can help find a trial for you!

Make 2nds Count has relaunched its free clinical trials service, helping secondary breast cancer patients, including those with triple negative breast cancer, find suitable trials. This nurse-led support offers expert guidance and tailored searches.

Read More →
Government Recognises That TNBC Needs A Specific Approach
Government Recognises That TNBC Needs A Specific Approach

Recently in parliament, government representatives recognised that a cancer specific approach is needed to meet the challenges in cancer care and to improve outcomes for people living with triple negative breast cancer.

Read More →
We are looking for more TNBC Champions!
We are looking for more TNBC Champions!

Apply now for the free TNBC Study Day on 21st March 2025 in London. Limited to 25 places, this CPD-certified event is your chance to become a TNBC Nurse Champion. Educate, engage, and lead as the expert in your team. Apply via RCNi today!

Read More →
Keytruda (Pembroluzimab) Positive Results!
Keytruda (Pembroluzimab) Positive Results!

Positive results have been shared by pharmaceutical company MSD from their recent trial with Keytruda, combined with chemotherapy, as a promising treatment for high-risk early-stage triple negative breast cancer patients

Read More →
The UK Charity for TNBC Becomes NICE Stakeholder
The UK Charity for TNBC Becomes NICE Stakeholder

The UK Charity for Triple Negative Breast Cancer is delighted to become a NICE stakeholder, contributing patient perspectives to the development of key breast cancer treatments.

Read More →
Education Grants for Nurses!
Education Grants for Nurses!

The UK Charity for Triple Negative Breast Cancer is delighted to be announcing a Foundation to provide grants to fund further education for individual breast cancer nurses.

Read More →
The UK Charity for TNBC Appears on BOPA Podcast
The UK Charity for TNBC Appears on BOPA Podcast

Robin Woolcock, founder of the UK Charity for Triple Negative Breast Cancer, joins Michal Sladkowski on the Let's Talk About SACT podcast. He discusses his experience with TNBC, the motivation behind the charity, and the support available for patients and staff.

Read More →